TUDOR INVESTMENT CORP ET AL - REATA PHARMACEUTICALS INC ownership

REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 149 filers reported holding REATA PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.53 and the average weighting 0.3%.

Quarter-by-quarter ownership
TUDOR INVESTMENT CORP ET AL ownership history of REATA PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$1,978
-99.3%
21,760
+83.9%
0.03%
+416.7%
Q3 2022$297,000
-15.1%
11,833
+2.6%
0.01%
-33.3%
Q2 2022$350,000
-19.0%
11,531
-12.5%
0.01%
-10.0%
Q1 2022$432,000
+84.6%
13,175
+48.3%
0.01%
+150.0%
Q4 2021$234,000
-88.4%
8,882
-55.6%
0.00%
-87.9%
Q3 2021$2,011,000
-9.0%
19,984
+27.9%
0.03%
-21.4%
Q2 2021$2,211,000
+0.4%
15,624
-29.3%
0.04%
-4.5%
Q1 2021$2,202,000
+34.7%
22,085
+67.0%
0.04%
-4.3%
Q4 2020$1,635,000
+36.7%
13,226
+72.5%
0.05%
-22.0%
Q2 2020$1,196,000
+39.9%
7,666
+29.4%
0.06%
-23.4%
Q1 2020$855,000
-49.4%
5,926
-28.3%
0.08%
+1.3%
Q4 2019$1,690,0008,2660.08%
Other shareholders
REATA PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
DekaBank Deutsche Girozentrale 17,000$2,9300.01%
PUBLIC EMPLOYEES RETIREMENT ASSOCIATION OF COLORADO 93,711$1,6120.00%
IFP Advisors, Inc 300$51,7080.00%
View complete list of REATA PHARMACEUTICALS INC shareholders